FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
SetBone Medical Announces $1.6 Million Financing
The funds raised will support the next stage of development and initiation of a First in Human pilot study.
PolyPhotonix Secures Multimillion Pound US Investment and Strategic Alliance for Sight Saving Mask
Prevail Partners, LLC, an affiliate of InfoWorks, has agreed to invest significantly in PolyPhotonix upon the commencement of the FDA clinical trial as lead investor in a $10M Series A investment round. Successful completion of the FDA clinical trial will open the US market to the treatment.
ENPICOM Secures Series B Funding
BOP Capital leads investment round supported by ENPICOM’s existing investors
Akura Medical, A New Shifamed Portfolio Company, Closes $25M in an Oversubscribed Series A1 Financing
The financing was led by Cormorant Asset Management, with participation from The Capital Partnership (TCP), PA MedTech VC Fund and Shifamed angel investors.
BPOC Makes Strategic Growth Investment in Network Partners
Network Partners has rapidly grown its client base in life sciences as demand for subject matter experts in niche areas continues to rise.
Henkel Invests in Medical Technology Start-up Smartz AG
Michael Spooner, Executive Chairman, Smartz AG notes, “Our partnership with Henkel is a world leading initiative. It delivers the strength, certainty, and service quality demanded by our customers, together with a cloud based and App driven technology that embodies decades of real-world experience in adult care..
Kiddo Announces $16M in Growth Investment to Address the Growing Need for Remote Patient Monitoring and Care Coordination for At-Risk Children
“Adoption of telehealth services accelerated during the pandemic, but physicians and parents supporting children with chronic conditions still need real-time data to make decisions, such as how to adjust medications, whether the advised treatment is working, or if a patient needs to be seen immediately,” said Kiddo Chief Medical Officer Rishi Madhok, MD.
URO-1 Achieves Multiple Milestones Toward Commercializing Its Breakthrough Products for Prostate Biopsy & Other Procedures
URO-1, established in 2017, is an emerging portfolio company of the North Carolina Biotechnology Center which in 2018 provided a $250,000 loan to support the company's early product development.
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
expedited its development after the company closed Series B financing in September 2021. It recently acquired Ann Arbor Pharmacometrics Group